Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Stonepine Capital Management, LLC (CIK 1440771) reported $249.7M across 55 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: XBI ($102.2M, 40.92%), VSTM ($17.5M, 7.01%), ADMA ($17.0M, 6.82%), TENX ($15.6M, 6.24%), EOLS ($9.0M, 3.59%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | XBI | SPDR SERIES TRUST | $102.2M | 40.92% | 800,000 | New |
| 2 | VSTM | VERASTEM INC | $17.5M | 7.01% | 3.3M | Added |
| 3 | ADMA | ADMA BIOLOGICS INC | $17.0M | 6.82% | 1.9M | Added |
| 4 | TENX | TENAX THERAPEUTICS INC | $15.6M | 6.24% | 975,200 | Added |
| 5 | EOLS | EVOLUS INC | $9.0M | 3.59% | 2.2M | Added |
| 6 | NKTR | NEKTAR THERAPEUTICS | $6.1M | 2.45% | 85,000 | Trimmed |
| 7 | CAMP | CAMP4 THERAPEUTICS CORP | $6.1M | 2.45% | 1.4M | Added |
| 8 | TERN | TERNS PHARMACEUTICALS INC | $5.3M | 2.11% | 100,000 | New |
| 9 | ZVRA | ZEVRA THERAPEUTICS INC | $4.5M | 1.79% | 480,000 | Trimmed |
| 10 | ABEO | ABEONA THERAPEUTICS INC | $3.8M | 1.52% | 846,587 | Trimmed |
| 11 | CRBP | CORBUS PHARMACEUTICALS HLDGS | $3.6M | 1.44% | 383,462 | Trimmed |
| 12 | ESTA | ESTABLISHMENT LABS HLDGS INC | $3.2M | 1.27% | 56,000 | New |
| 13 | KZIA | KAZIA THERAPEUTICS LTD | $2.6M | 1.03% | 345,179 | Trimmed |
| 14 | ANTX | AN2 THERAPEUTICS INC | $2.4M | 0.98% | 713,845 | Added |
| 15 | ARE | ALEXANDRIA REAL ESTATE EQ IN | $2.3M | 0.93% | 50,000 | Hold |
| 16 | ACAD | ACADIA PHARMACEUTICALS INC | $2.2M | 0.89% | 100,000 | Hold |
| 17 | SLGL | SOL-GEL TECHNOLOGIES LTD | $2.2M | 0.88% | 27,778 | New |
| 18 | XOMA | XOMA ROYALTY CORPORATION | $2.2M | 0.87% | 69,500 | Trimmed |
| 19 | AYTU | AYTU BIOPHARMA INC | $2.2M | 0.87% | 792,289 | Trimmed |
| 20 | CRIS | CURIS INC | $2.0M | 0.82% | 3.7M | Added |
| 21 | HRTX | HERON THERAPEUTICS INC | $1.9M | 0.77% | 2.4M | Added |
| 22 | CTMX | CYTOMX THERAPEUTICS INC. | $1.9M | 0.75% | 400,000 | New |
| 23 | XERS | XERIS BIOPHARMA HOLDINGS INC | $1.9M | 0.74% | 320,030 | New |
| 24 | TELA | TELA BIO INC | $1.6M | 0.65% | 2.6M | Added |
| 25 | IKT | INHIBIKASE THERAPEUTICS INC | $1.6M | 0.64% | 957,202 | Trimmed |
Source: SEC Form 13F filings · as of 2026-03-31